5α-Dihydronormethandrone
A synthetic anabolic-androgenic steroid

5α-Dihydronormethandrone (5α-DHN) is a synthetic anabolic-androgenic steroid (AAS) and a derivative of nandrolone. It is a metabolite of the prohormone methyldienolone and is known for its potent androgenic effects.
Chemical Structure and Properties[edit]
5α-Dihydronormethandrone is a 5α-reduced derivative of normethandrone, which itself is a derivative of nandrolone. The chemical structure of 5α-DHN is characterized by the presence of a 5α-hydrogen atom, which distinguishes it from its parent compound. This modification enhances its binding affinity to the androgen receptor, contributing to its potent androgenic activity.
Pharmacology[edit]
5α-Dihydronormethandrone acts primarily as an agonist of the androgen receptor. Its anabolic effects are mediated through the activation of this receptor, leading to increased protein synthesis and muscle growth. The compound also exhibits androgenic effects, which are responsible for the development of male secondary sexual characteristics.
Metabolism[edit]
5α-DHN is a metabolite of methyldienolone, a potent oral anabolic steroid. The conversion to 5α-DHN occurs via the action of the enzyme 5α-reductase, which reduces the double bond in the A-ring of the steroid structure. This metabolic pathway is similar to the conversion of testosterone to dihydrotestosterone (DHT).
Clinical Use[edit]
5α-Dihydronormethandrone itself is not used clinically. However, its parent compound, methyldienolone, has been investigated for its potential use in treating conditions such as muscle wasting and osteoporosis. The potent androgenic effects of 5α-DHN limit its therapeutic applications due to the risk of androgenic side effects.
Side Effects[edit]
The use of 5α-Dihydronormethandrone, like other anabolic steroids, can lead to a range of side effects. These may include:
The risk of these side effects is heightened due to the compound's strong androgenic properties.
Legal Status[edit]
5α-Dihydronormethandrone is classified as a controlled substance in many countries due to its potential for abuse and adverse health effects. It is included in the list of substances banned by the World Anti-Doping Agency (WADA) for use in sports.
Related Pages[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian